A role of peptidergic nerves in the internal anal sphincter of Hirschsprung's disease

BACKGROUND: It is not clear what contribution the internal anal sphincter makes to the impaired motility observed in patients with Hirschsprung's disease (HD). Neuropeptides have recently been shown to be neurotransmitters in the nonadrenergic, noncholinergic inhibitory and excitatory nerves in the human gut. To clarify the physiologic significance of vasoactive intestinal polypeptide and substance P in the internal anal sphincter of HD (aganglionosis), we investigated the enteric nerve responses on lesional and normal internal anal sphincter muscle strips above the dentate line.

METHODS: The lesional and normal internal anal sphincter muscle strips above the dentate line were derived from patient with HD (9 cases) and patients who underwent rectal amputation for low rectal cancers (8 cases). A mechanographic technique was used to evaluate in vitro muscle responses to these peptides of adrenergic and cholinergic nerves before and after treatment with various autonomic nerve blockers.

RESULTS: Nonadrenergic, noncholinergic inhibitory nerves were found to act on the normal internal anal sphincter but had no effect on the enteric nerves in aganglionosis. Peptidergic (vasoactive intestinal polypeptide and substance P) nerves were found to act on normal colon, but no effect was observed in the aganglionic internal anal sphincter.

CONCLUSIONS: These findings suggest that peptidergic nerves play an important role in the impaired motility observed in the internal anal sphincter with HD.

Medienart:

Artikel

Erscheinungsjahr:

1999

Erschienen:

1999

Enthalten in:

Zur Gesamtaufnahme - volume:125

Enthalten in:

Surgery - 125(1999), 1 vom: 01. Jan., Seite 60-6

Sprache:

Englisch

Beteiligte Personen:

Tomita, R [VerfasserIn]
Morita, K [VerfasserIn]
Tanjoh, K [VerfasserIn]
Munakata, K [VerfasserIn]

Themen:

0TTZ664R7Z
33507-63-0
37221-79-7
4368-28-9
7C0697DR9I
9Y8NXQ24VQ
Atropine
Journal Article
Phenoxybenzamine
Propranolol
Substance P
Tetrodotoxin
Vasoactive Intestinal Peptide

Anmerkungen:

Date Completed 28.01.1999

Date Revised 07.12.2017

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM098250434